What insurance policy changes affect CPT 62321?

There are 11 tracked policy changes affecting CPT 62321, including updates from Humana, Harvard Pilgrim Health Care, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 62321?

Payers that have issued tracked updates for CPT 62321 include: Humana, Harvard Pilgrim Health Care, Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when CPT 62321 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 62321. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 62321?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

62321 — A doctor injects medication into the space between the spine bones in your neck or upper back to reduce pain and inflammation.: Insurance Policy Changes

62321 Insurance Policy Changes

CPT 62321, in plain terms, covers A doctor injects medication into the space between the spine bones in your neck or upper back to reduce pain and inflammation. CPT 62321 is referenced in 11 tracked payer policy changes from Humana, Harvard Pilgrim Health Care, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 62321 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (Revised)

Humana·Effective Jul 29, 2026

Humana Oklahoma Medicaid updated its policy for chronic pain injections (epidural steroid injections, facet joint injections, sacroiliac joint injections, trigger point injections, and peripheral nerve blocks) effective July 29, 2026. The policy establishes specific coverage criteria including mandatory 4-week conservative treatment, radicular pain confirmation, imaging guidance requirements, and strict frequency/level limitations for procedures. Billing teams must ensure prior authorization compliance and proper documentation of conservative treatment attempts before claim submission.

62321 Insurance Policy Changes

Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (Revised)

Injections for Chronic Pain Conditions - MEDICAID - KENTUCKY (Revised)

Injections for Chronic Pain Conditions - MEDICAID - FLORIDA (Revised)

Injections for Chronic Pain Conditions - MEDICAID - VIRGINIA (Revised)

Injections for Chronic Pain Conditions - MEDICAID - MICHIGAN (New)

Injections for Chronic Pain Conditions - MEDICAID - ILLINOIS (New)

Injections for Chronic Pain Conditions - MEDICAID - OKLAHOMA (New)

Reminder: Expansion of vendor program and training sessions

Onasemnogene Abeparvovec (Zolgensma and Itvisma) (CPB 0953, reviewed 2026-08-10)

Epidural Steroid Injections

Epidural, Intrathecal, and Intraventricular Morphine Administration